GBR 12935 (BioDeep_00001875296)
代谢物信息卡片
1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine
化学式: C28H34N2O (414.2670994)
中文名称: GBR 12935
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
InChI: InChI=1S/C28H34N2O/c1-4-11-25(12-5-1)13-10-18-29-19-21-30(22-20-29)23-24-31-28(26-14-6-2-7-15-26)27-16-8-3-9-17-27/h1-9,11-12,14-17,28H,10,13,18-24H2
描述信息
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents
D049990 - Membrane Transport Modulators
同义名列表
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Wei Yang, Adam C Munhall, Steven W Johnson. Dopamine Evokes a Trace Amine Receptor-dependent Inward Current that is Regulated by AMP Kinase in Substantia Nigra Dopamine Neurons.
Neuroscience.
2020 02; 427(?):77-91. doi:
10.1016/j.neuroscience.2019.11.044. [PMID: 31883822] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - David H Root, Alexander F Hoffman, Cameron H Good, Shiliang Zhang, Eduardo Gigante, Carl R Lupica, Marisela Morales. Norepinephrine activates dopamine D4 receptors in the rat lateral habenula.
The Journal of neuroscience : the official journal of the Society for Neuroscience.
2015 Feb; 35(8):3460-9. doi:
10.1523/jneurosci.4525-13.2015. [PMID: 25716845] - Y Simchon, A Weizman, M Rehavi. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.
2010 Oct; 20(10):714-20. doi:
10.1016/j.euroneuro.2010.04.007. [PMID: 20493667] - M Hill, R J L Anney, M Gill, Z Hawi. Functional analysis of intron 8 and 3' UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants.
The pharmacogenomics journal.
2010 Oct; 10(5):442-7. doi:
10.1038/tpj.2009.66. [PMID: 20029387] - Tomonori Fujiwara, Masumi Snada, Takefumi Kofuji, Takeo Yoshikawa, Kimio Akagawa. HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems.
The European journal of neuroscience.
2010 Jul; 32(1):99-107. doi:
10.1111/j.1460-9568.2010.07269.x. [PMID: 20576034] - Jun Zhu, Charles F Mactutus, David R Wallace, Rosemarie M Booze. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
The Journal of pharmacology and experimental therapeutics.
2009 Jun; 329(3):1071-83. doi:
10.1124/jpet.108.150144. [PMID: 19325033] - Ling-Wei Hsin, Li-Te Chang, Richard B Rothman, Christina M Dersch, Arthur E Jacobson, Kenner C Rice. Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters.
Journal of medicinal chemistry.
2008 May; 51(9):2795-806. doi:
10.1021/jm701270n. [PMID: 18393401] - Foteini Delis, Ada Mitsacos, Panagiotis Giompres. Pharmacological characterization and anatomical distribution of the dopamine transporter in the mouse cerebellum.
Cerebellum (London, England).
2008; 7(3):242-51. doi:
10.1007/s12311-008-0005-4. [PMID: 18418665] - Lisa S Middleton, Subbu Apparsundaram, Kelley A King-Pospisil, Linda P Dwoskin. Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism.
European journal of pharmacology.
2007 Jan; 554(2-3):128-36. doi:
10.1016/j.ejphar.2006.09.074. [PMID: 17141211] - Giuseppe Battaglia, Maria Grazia Farrace, Pier Giorgio Mastroberardino, Irene Viti, Gian Maria Fimia, Jozef Van Beeumen, Bart Devreese, Gennaro Melino, Gemma Molinaro, Carla Letizia Busceti, Francesca Biagioni, Ferdinando Nicoletti, Mauro Piacentini. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.
Journal of neurochemistry.
2007 Jan; 100(1):36-49. doi:
10.1111/j.1471-4159.2006.04140.x. [PMID: 17064362] - Luciano Minuzzi, Aage Kristian Olsen, Dirk Bender, Sidse Arnfred, Rebecca Grant, Erik H Danielsen, Paul Cumming. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Synapse (New York, N.Y.).
2006 Mar; 59(4):211-9. doi:
10.1002/syn.20234. [PMID: 16385509] - Jarod Swant, John J Wagner. Dopamine transporter blockade increases LTP in the CA1 region of the rat hippocampus via activation of the D3 dopamine receptor.
Learning & memory (Cold Spring Harbor, N.Y.).
2006 Mar; 13(2):161-7. doi:
10.1101/lm.63806. [PMID: 16585791] - X Jiao, W P Paré, S M Tejani-Butt. Alcohol consumption alters dopamine transporter sites in Wistar-Kyoto rat brain.
Brain research.
2006 Feb; 1073-1074(?):175-82. doi:
10.1016/j.brainres.2005.12.009. [PMID: 16457790] - Xilu Jiao, William P Paré, Shanaz M Tejani-Butt. Antidepressant drug induced alterations in binding to central dopamine transporter sites in the Wistar Kyoto rat strain.
Progress in neuro-psychopharmacology & biological psychiatry.
2006 Jan; 30(1):30-41. doi:
10.1016/j.pnpbp.2005.06.017. [PMID: 16091300] - Guillaume Hébert, Rozenn Mingam, Josette Arsaut, Robert Dantzer, Jacques Demotes-Mainard. A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice.
Brain research. Molecular brain research.
2005 May; 136(1-2):267-70. doi:
10.1016/j.molbrainres.2005.01.009. [PMID: 15893609] - Krystyna Ossowska, Jadwiga Wardas, Katarzyna Kuter, Przemysław Nowak, Joanna Dabrowska, Aleksandra Bortel, Łukasz Labus, Adam Kwieciński, Anna Krygowska-Wajs, Stainsław Wolfarth. Influence of paraquat on dopaminergic transporter in the rat brain.
Pharmacological reports : PR.
2005 May; 57(3):330-5. doi:
. [PMID: 15985715] - Subroto Ghose, Masahiro Fujita, Paul Morrison, George Uhl, Dennis L Murphy, P David Mozley, Magnus Schou, Christer Halldin, Robert Innis. Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.
Synapse (New York, N.Y.).
2005 May; 56(2):100-4. doi:
10.1002/syn.20133. [PMID: 15729740] - Juan Zhen, Soumen Maiti, Nianhang Chen, Aloke K Dutta, Maarten E A Reith. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter.
European journal of pharmacology.
2004 Dec; 506(1):17-26. doi:
10.1016/j.ejphar.2004.10.028. [PMID: 15588620] - Elzbieta Lorenc-Koci, Lucyna Antkiewicz-Michaluk, Jadwiga Wardas, Małgorzata Zapała, Joanna Wierońska. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
Brain research.
2004 May; 1009(1-2):67-81. doi:
10.1016/j.brainres.2004.02.044. [PMID: 15120584] - Jon D Gaffaney, Roxanne A Vaughan. Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter.
Molecular pharmacology.
2004 Mar; 65(3):692-701. doi:
10.1124/mol.65.3.692. [PMID: 14978248] - Nianhang Chen, Judy Rickey, Janet L Berfield, Maarten E A Reith. Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding.
The Journal of biological chemistry.
2004 Feb; 279(7):5508-19. doi:
10.1074/jbc.m306294200. [PMID: 14660644] - Jun Zhu, Thomas Green, Michael T Bardo, Linda P Dwoskin. Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex.
Behavioural brain research.
2004 Jan; 148(1-2):107-17. doi:
10.1016/s0166-4328(03)00190-6. [PMID: 14684252] - Guillaume Hébert, Josette Arsaut, Robert Dantzer, Jacques Demotes-Mainard. Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin.
Neuroscience letters.
2003 Oct; 349(3):191-5. doi:
10.1016/s0304-3940(03)00832-2. [PMID: 12951201] - Makoto Kimura, Tomoko Masuda, Koji Yamada, Masaki Mitani, Nobuo Kubota, Nobuyuki Kawakatsu, Kenichi Kishii, Masato Inazu, Yuji Kiuchi, Katsuji Oguchi, Takayuki Namiki. Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
Bioorganic & medicinal chemistry.
2003 Sep; 11(18):3953-63. doi:
10.1016/s0968-0896(03)00428-0. [PMID: 12927856] - P Govitrapong, P Vilaipun, M Ebadi. Identification of dopamine transporter in bovine pineal gland using [3H]GBR 12935.
Journal of pineal research.
2003 Aug; 35(1):16-23. doi:
10.1034/j.1600-079x.2003.00033.x. [PMID: 12823609] - Jyoti Patel, Katrin A Mooslehner, Pok Man Chan, Piers C Emson, Jonathan A Stamford. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Journal of neurochemistry.
2003 May; 85(4):898-910. doi:
10.1046/j.1471-4159.2003.01732.x. [PMID: 12716422] - David Lewis, Ying Zhang, Thomas Prisinzano, Christina M Dersch, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter.
Bioorganic & medicinal chemistry letters.
2003 Apr; 13(7):1385-9. doi:
10.1016/s0960-894x(03)00108-2. [PMID: 12657288] - Sujit K Ghorai, Charles Cook, Matthew Davis, Sylesh K Venkataraman, Clifford George, Patrick M Beardsley, Maarten E A Reith, Aloke K Dutta. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
Journal of medicinal chemistry.
2003 Mar; 46(7):1220-8. doi:
10.1021/jm020275k. [PMID: 12646032] - Shigeaki Arai, Katsuya Morita, Shigeo Kitayama, Kei Kumagai, Michio Kumagai, Kenji Kihira, Toshihiro Dohi. Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics.
Brain research.
2003 Feb; 964(1):83-90. doi:
10.1016/s0006-8993(02)04068-4. [PMID: 12573515] - Heather L Kimmel, F Ivy Carroll, Michael J Kuhar. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum.
The Journal of pharmacology and experimental therapeutics.
2003 Jan; 304(1):15-21. doi:
10.1124/jpet.102.038018. [PMID: 12490570] - Sylvie Chalon, Jari Tarkiainen, Lucette Garreau, Hakan Hall, Patrick Emond, Johnny Vercouillie, Lars Farde, Philippe Dasse, Katarina Varnas, Jean-Claude Besnard, Christer Halldin, Denis Guilloteau. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
The Journal of pharmacology and experimental therapeutics.
2003 Jan; 304(1):81-7. doi:
10.1124/jpet.102.042226. [PMID: 12490578] - Feng C Zhou, Klaus-Peter Lesch, Dennis L Murphy. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
Brain research.
2002 Jun; 942(1-2):109-19. doi:
10.1016/s0006-8993(02)02709-9. [PMID: 12031859] - Ling-Wei Hsin, Christina M Dersch, Michael H Baumann, David Stafford, John R Glowa, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine.
Journal of medicinal chemistry.
2002 Mar; 45(6):1321-9. doi:
10.1021/jm010430f. [PMID: 11882001] - Guylène Page, Sylvie Chalon, Patrick Emond, Jean Marie Maloteaux, Emmanuel Hermans. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells.
Neurochemistry international.
2002 Feb; 40(2):105-13. doi:
10.1016/s0197-0186(01)00086-9. [PMID: 11738476] - Aloke K Dutta, Matthew C Davis, Xiang-Shu Fei, Patrick M Beardsley, Charles D Cook, Maarten E A Reith. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules.
Journal of medicinal chemistry.
2002 Jan; 45(3):654-62. doi:
10.1021/jm010316x. [PMID: 11806716] - Y Zhang, D B Joseph, W D Bowen, J L Flippen-Anderson, C M Dersch, R B Rothman, A E Jacobson, K C Rice. Synthesis and biological evaluation of tropane-like 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909) analogues.
Journal of medicinal chemistry.
2001 Nov; 44(23):3937-45. doi:
10.1021/jm0101592. [PMID: 11689080] - B H Falkenburger, K L Barstow, I M Mintz. Dendrodendritic inhibition through reversal of dopamine transport.
Science (New York, N.Y.).
2001 Sep; 293(5539):2465-70. doi:
10.1126/science.1060645. [PMID: 11577238] - H L Kimmel, F I Carroll, M J Kuhar. RTI-76, an irreversible inhibitor of dopamine transporter binding, increases locomotor activity in the rat at high doses.
Brain research.
2001 Apr; 897(1-2):157-63. doi:
10.1016/s0006-8993(01)02118-7. [PMID: 11282369] - S R Tella, S R Goldberg. Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909.
Progress in neuro-psychopharmacology & biological psychiatry.
2001 Apr; 25(3):639-56. doi:
10.1016/s0278-5846(00)00180-9. [PMID: 11371002] - M Cyr, M Morissette, N Barden, S Beaulieu, J Rochford, T Di Paolo. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Neuroscience.
2001; 102(1):151-8. doi:
10.1016/s0306-4522(00)00444-9. [PMID: 11226678] - G H Moll, S Hause, E Rüther, A Rothenberger, G Huether. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters.
Journal of child and adolescent psychopharmacology.
2001; 11(1):15-24. doi:
10.1089/104454601750143366. [PMID: 11322741] - B T Hoffman, T Kopajtic, J L Katz, A H Newman. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
Journal of medicinal chemistry.
2000 Nov; 43(22):4151-9. doi:
10.1021/jm990472s. [PMID: 11063611] - K M Erikson, B C Jones, J L Beard. Iron deficiency alters dopamine transporter functioning in rat striatum.
The Journal of nutrition.
2000 Nov; 130(11):2831-7. doi:
10.1093/jn/130.11.2831. [PMID: 11053528] - S Callier, M Morissette, M Grandbois, T Di Paolo. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
Synapse (New York, N.Y.).
2000 Sep; 37(4):245-51. doi:
10.1002/1098-2396(20000915)37:4<245::aid-syn1>3.0.co;2-5. [PMID: 10891861] - H L Kimmel, F I Carroll, M J Kuhar. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
Neuropharmacology.
2000 Feb; 39(4):578-85. doi:
10.1016/s0028-3908(99)00160-4. [PMID: 10728879] - G H Moll, C Mehnert, M Wicker, N Bock, A Rothenberger, E Rüther, G Huether. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
Brain research. Developmental brain research.
2000 Feb; 119(2):251-7. doi:
10.1016/s0165-3806(99)00182-0. [PMID: 10675775] - S W Choi, D R Elmaleh, R N Hanson, A J Fischman. Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.
Journal of medicinal chemistry.
2000 Jan; 43(2):205-13. doi:
10.1021/jm9902178. [PMID: 10649976] - N S Kula, R J Baldessarini, F I Tarazi, R Fisser, S Wang, J Trometer, J L Neumeyer. [3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue.
European journal of pharmacology.
1999 Dec; 385(2-3):291-4. doi:
10.1016/s0014-2999(99)00695-0. [PMID: 10607889] - D B Lewis, D Matecka, Y Zhang, L W Hsin, C M Dersch, D Stafford, J R Glowa, R B Rothman, K C Rice. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.
Journal of medicinal chemistry.
1999 Dec; 42(24):5029-42. doi:
10.1021/jm990291q. [PMID: 10585212] - S W Choi, D R Elmaleh, R N Hanson, A J Fischman. Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.
Journal of medicinal chemistry.
1999 Sep; 42(18):3647-56. doi:
10.1021/jm990161h. [PMID: 10479296] - K Zimmermann, B Hengerer. Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons.
Bioorganic & medicinal chemistry letters.
1998 Feb; 8(3):261-6. doi:
10.1016/s0960-894x(98)00003-1. [PMID: 9871666] - M Watanabe, R Nonaka, Y Hagino, Y Kodama. Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain.
Neuroscience research.
1998 Feb; 30(2):135-44. doi:
10.1016/s0168-0102(97)00123-5. [PMID: 9579647] - L P Shearman, J S Meyer. Norepinephrine transporters in rat placenta labeled with [3H]nisoxetine.
The Journal of pharmacology and experimental therapeutics.
1998 Feb; 284(2):736-43. doi:
NULL. [PMID: 9454822] - A T Corera, J C Do Régo, J J Bonnet. Specificity and ion dependence of binding of GBR analogs.
Methods in enzymology.
1998; 296(?):203-19. doi:
10.1016/s0076-6879(98)96016-5. [PMID: 9779450] - C Bowden, S C Cheetham, S Lowther, C L Katona, M R Crompton, R W Horton. Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.
1997 Nov; 7(4):247-52. doi:
10.1016/s0924-977x(97)00423-9. [PMID: 9443655] - T Hiroi, S Imaoka, T Chow, Y Yabusaki, Y Funae. Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6.
Biochemical pharmacology.
1997 Jun; 53(12):1937-9. doi:
10.1016/s0006-2952(97)00172-x. [PMID: 9256169] - P Emond, L Garreau, S Chalon, M Boazi, M Caillet, J Bricard, Y Frangin, L Mauclaire, J C Besnard, D Guilloteau. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter.
Journal of medicinal chemistry.
1997 Apr; 40(9):1366-72. doi:
10.1021/jm960795d. [PMID: 9135033] - D Matecka, D Lewis, R B Rothman, C M Dersch, F H Wojnicki, J R Glowa, A C DeVries, A Pert, K C Rice. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
Journal of medicinal chemistry.
1997 Feb; 40(5):705-16. doi:
10.1021/jm9606599. [PMID: 9057857] - D Matecka, R B Rothman, L Radesca, B R de Costa, C M Dersch, J S Partilla, A Pert, J R Glowa, F H Wojnicki, K C Rice. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Journal of medicinal chemistry.
1996 Nov; 39(24):4704-16. doi:
10.1021/jm960305h. [PMID: 8941383] - E Koutsilieri, J Kornhuber, H J Degen, K P Lesch, S Sopper, V ter Meulen, P Riederer. U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters.
Journal of neuroscience research.
1996 Aug; 45(3):269-75. doi:
10.1002/(sici)1097-4547(19960801)45:3<269::aid-jnr8>3.0.co;2-b. [PMID: 8841987] - L M Collins, J S Meyer. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
Synapse (New York, N.Y.).
1996 Aug; 23(4):335-43. doi:
10.1002/(sici)1098-2396(199608)23:4<335::aid-syn12>3.0.co;2-w. [PMID: 8855519] - R Azoui, J L Cuche, J F Renaud, M Safar, G Dagher. A dopamine transporter in human erythrocytes: modulation by insulin.
Experimental physiology.
1996 May; 81(3):421-34. doi:
10.1113/expphysiol.1996.sp003946. [PMID: 8737076] - H N Bhargava, K P Gudehithlu. Chronic blockade of opioid receptors alters the binding of [3H]GBR 12935 to dopamine transporter in rat brain regions and spinal cord.
Pharmacology.
1996 Apr; 52(4):243-51. doi:
10.1159/000139389. [PMID: 8841087] - I Gordon, R Weizman, M Rehavi. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
European journal of pharmacology.
1996 Feb; 298(1):27-30. doi:
10.1016/0014-2999(95)00770-9. [PMID: 8867915] - K P Gudehithlu, H N Bhargava. Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats.
Neuropharmacology.
1996 Feb; 35(2):169-74. doi:
10.1016/0028-3908(95)00165-4. [PMID: 8734485] - R Rivest, P Falardeau, T Di Paolo. Brain dopamine transporter: gender differences and effect of chronic haloperidol.
Brain research.
1995 Sep; 692(1-2):269-72. doi:
10.1016/0006-8993(95)00611-s. [PMID: 8548314] - L H Claye, H C Akunne, M D Davis, S DeMattos, K F Soliman. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Molecular neurobiology.
1995 Aug; 11(1-3):55-66. doi:
10.1007/bf02740684. [PMID: 8561968] - A J Eshleman, R L Neve, A Janowsky, K A Neve. Characterization of a recombinant human dopamine transporter in multiple cell lines.
The Journal of pharmacology and experimental therapeutics.
1995 Jul; 274(1):276-83. doi:
NULL. [PMID: 7616409] - I Gordon, R Weizman, E Rosenne, M Rehavi. Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms.
Brain research. Developmental brain research.
1995 Apr; 85(2):225-8. doi:
10.1016/0165-3806(94)00216-m. [PMID: 7600670] - J W Boja, J L Cadet, T A Kopajtic, J Lever, H H Seltzman, C D Wyrick, A H Lewin, P Abraham, F I Carroll. Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.
Molecular pharmacology.
1995 Apr; 47(4):779-86. doi:
NULL. [PMID: 7723739] - I Gordon, R Weizman, M Rehavi. [3H]GBR 12935 labels mainly the piperazine acceptor site in the rat prefrontal cortex.
Brain research.
1995 Mar; 674(2):205-10. doi:
10.1016/0006-8993(95)00007-d. [PMID: 7796098] - A Hitri, M F Casanova, J E Kleinman, D R Weinberger, R J Wyatt. Age-related changes in [3H]GBR 12935 binding site density in the prefrontal cortex of controls and schizophrenics.
Biological psychiatry.
1995 Feb; 37(3):175-82. doi:
10.1016/0006-3223(94)00202-e. [PMID: 7727626] - J M Wilson, J N Nobrega, W A Corrigall, K M Coen, K Shannak, S J Kish. Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine.
Brain research.
1994 Dec; 668(1-2):39-45. doi:
10.1016/0006-8993(94)90508-8. [PMID: 7704616] - R B Rothman, J L Cadet, H C Akunne, M L Silverthorn, M H Baumann, F I Carroll, K C Rice, B R de Costa, J S Partilla, J B Wang. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
The Journal of pharmacology and experimental therapeutics.
1994 Jul; 270(1):296-309. doi:
NULL. [PMID: 8035327] - J M Wilson, J N Nobrega, M E Carroll, H B Niznik, K Shannak, S T Lac, Z B Pristupa, L M Dixon, S J Kish. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
The Journal of neuroscience : the official journal of the Society for Neuroscience.
1994 May; 14(5 Pt 2):2966-79. doi:
10.1523/jneurosci.14-05-02966.1994. [PMID: 8182452] - H E Milner, R Béliveau, S M Jarvis. The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation.
Biochimica et biophysica acta.
1994 Feb; 1190(1):185-7. doi:
10.1016/0005-2736(94)90051-5. [PMID: 8110814] - Z B Pristupa, J M Wilson, B J Hoffman, S J Kish, H B Niznik. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Molecular pharmacology.
1994 Jan; 45(1):125-35. doi:
NULL. [PMID: 8302271] - R Simantov. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction.
Neuroscience letters.
1993 Dec; 163(2):121-4. doi:
10.1016/0304-3940(93)90360-w. [PMID: 8309616] - A Hitri, R J Wyatt. Regional differences in rat brain dopamine transporter binding: function of time after chronic cocaine.
Clinical neuropharmacology.
1993 Dec; 16(6):525-39. doi:
10.1097/00002826-199312000-00006. [PMID: 9377588] - R B Rothman, B Lewis, C Dersch, H Xu, L Radesca, B R de Costa, K C Rice, R B Kilburn, H C Akunne, A Pert. Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters.
Synapse (New York, N.Y.).
1993 May; 14(1):34-9. doi:
10.1002/syn.890140106. [PMID: 8511716] - E K Richfield. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.
Molecular pharmacology.
1993 Jan; 43(1):100-8. doi:
NULL. [PMID: 8423763] - R B Rothman, K M Becketts, L R Radesca, B R de Costa, K C Rice, F I Carroll, C M Dersch. Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists.
Life sciences.
1993; 53(17):PL267-72. doi:
10.1016/0024-3205(93)90602-y. [PMID: 8412496] - H E Milner, S M Jarvis. Ionic requirements of [3H]GBR-12935 binding to the dopamine transporter in canine striatal membranes.
Biochemical Society transactions.
1992 Aug; 20(3):243S. doi:
10.1042/bst020243s. [PMID: 1426538] - N A Sharif, J L Nunes, V Kalfayan, D L McClelland, R P Rosenkranz, R M Eglen, R L Whiting. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?.
Neurochemistry international.
1992 Jul; 21(1):69-73. doi:
10.1016/0197-0186(92)90068-3. [PMID: 1303143] - G M Farfel, M S Kleven, W L Woolverton, L S Seiden, B D Perry. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Brain research.
1992 Apr; 578(1-2):235-43. doi:
10.1016/0006-8993(92)90252-5. [PMID: 1380862] - A Patel, J W Boja, J Lever, R Lew, R Simantov, F I Carroll, A H Lewin, A Philip, Y Gao, M J Kuhar. A cocaine analog and a GBR analog label the same protein in rat striatal membranes.
Brain research.
1992 Mar; 576(1):173-4. doi:
10.1016/0006-8993(92)90627-l. [PMID: 1515909] - A Hamdi, C Prasad. Attenuation of pulsatile changes in the density of striatal [3H]GBR-12935 binding sites during chronic ethanol consumption.
Brain research.
1991 Dec; 567(1):71-5. doi:
10.1016/0006-8993(91)91437-6. [PMID: 1815831] - E K Richfield. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Brain research.
1991 Feb; 540(1-2):1-13. doi:
10.1016/0006-8993(91)90486-f. [PMID: 1829013] - N S Kula, R J Baldessarini. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
Neuropharmacology.
1991 Jan; 30(1):89-92. doi:
10.1016/0028-3908(91)90047-f. [PMID: 2046881] - H B Niznik, E F Fogel, F F Fassos, P Seeman. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus.
Journal of neurochemistry.
1991 Jan; 56(1):192-8. doi:
10.1111/j.1471-4159.1991.tb02580.x. [PMID: 1987318] - M Morissette, D Biron, T Di Paolo. Effect of estradiol and progesterone on rat striatal dopamine uptake sites.
Brain research bulletin.
1990 Sep; 25(3):419-22. doi:
10.1016/0361-9230(90)90231-n. [PMID: 2292039] - P Berger, J D Elsworth, J Arroyo, R H Roth. Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.
European journal of pharmacology.
1990 Feb; 177(1-2):91-4. doi:
10.1016/0014-2999(90)90554-j. [PMID: 1967129] - H B Niznik, R F Tyndale, F R Sallee, F J Gonzalez, J P Hardwick, T Inaba, W Kalow. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
Archives of biochemistry and biophysics.
1990 Feb; 276(2):424-32. doi:
10.1016/0003-9861(90)90741-g. [PMID: 2306106] - R B Rothman, A Mele, A A Reid, H Akunne, N Greig, A Thurkauf, K C Rice, A Pert. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development.
FEBS letters.
1989 Nov; 257(2):341-4. doi:
10.1016/0014-5793(89)81566-2. [PMID: 2583282]